Literature DB >> 18164588

Heterodimers of adenylyl cyclases 2 and 5 show enhanced functional responses in the presence of Galpha s.

Alessandra Baragli1, Maria-Laura Grieco, Phan Trieu, Louis R Villeneuve, Terence E Hébert.   

Abstract

Recent studies have demonstrated that adenylyl cyclase isoforms can form both homo- and heterodimers and that this may be the basic functional unit of these enzymes (see Cooper, D.M.F. and Crossthwaite, A.J. (2006) Trends. Pharmacol. Sci. 8:426-431). Here, we show that adenylyl cyclases 2 and 5 can form a functional heterodimeric complex in HEK293 cells using a combination of BRET, confocal imaging, co-immunoprecipitation and assays of adenylyl cyclase activity. The AC2/5 complex is formed constitutively and is stable in the presence of receptor or forskolin stimulation. The complex formed by AC2/5 is also much more sensitive to the presence of Galpha(s) and forskolin than either of the parent AC isoforms themselves. Finally, we also show that this complex can be detected in native tissues as AC2 and AC5 were localized to the same structures in adult mouse ventricular myocytes and neonatal mouse cardiac fibroblasts and could be co-immunoprecipitated from lysates of mouse heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164588     DOI: 10.1016/j.cellsig.2007.10.033

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  13 in total

Review 1.  The role of G proteins in assembly and function of Kir3 inwardly rectifying potassium channels.

Authors:  Peter Zylbergold; Nitya Ramakrishnan; Terence Hebert
Journal:  Channels (Austin)       Date:  2010-09-01       Impact factor: 2.581

2.  Soluble adenylyl cyclase activity is necessary for retinal ganglion cell survival and axon growth.

Authors:  Raul G Corredor; Ephraim F Trakhtenberg; Wolfgang Pita-Thomas; Xiaolu Jin; Ying Hu; Jeffrey L Goldberg
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

3.  The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart.

Authors:  Yong Li; Lei Chen; Robert S Kass; Carmen W Dessauer
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

Review 4.  Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling.

Authors:  George Vaniotis; Bruce G Allen; Terence E Hébert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

Review 5.  Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling.

Authors:  Pierre-Alexandre Vidi; Karin F K Ejendal; Julie A Przybyla; Val J Watts
Journal:  Mol Cell Endocrinol       Date:  2010-07-21       Impact factor: 4.102

6.  Interferon-gamma inhibits adenosine A2A receptor function in hepatic stellate cells by STAT1-mediated repression of adenylyl cyclase.

Authors:  Eric T Block; Bruce N Cronstein
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2010-10

7.  E and M circadian pacemaker neurons use different PDF receptor signalosome components in drosophila.

Authors:  Laura B Duvall; Paul H Taghert
Journal:  J Biol Rhythms       Date:  2013-08       Impact factor: 3.182

8.  Store-operated cyclic AMP signalling mediated by STIM1.

Authors:  Konstantinos Lefkimmiatis; Meera Srikanthan; Isabella Maiellaro; Mary Pat Moyer; Silvana Curci; Aldebaran M Hofer
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824

Review 9.  The role of Gbetagamma subunits in the organization, assembly, and function of GPCR signaling complexes.

Authors:  Denis J Dupré; Mélanie Robitaille; R Victor Rebois; Terence E Hébert
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

10.  The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae.

Authors:  Muthusamy Thangavel; Xiaoqiu Liu; Shu Qiang Sun; Joseph Kaminsky; Rennolds S Ostrom
Journal:  Cell Signal       Date:  2008-11-05       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.